Search Results - "HEMMEN, Thomas M"

Evolving Healthcare Delivery in Neurology During the Coronavirus Disease 2019 (COVID-19) Pandemic by Chen, Patrick M, Hemmen, Thomas M

Get full text

Stroke Severity Is a Crucial Predictor of Outcome: An International Prospective Validation Study by Rost, Natalia S., Bottle, Alex, Lee, Jin‐Moo, Randall, Marc, Middleton, Steven, Shaw, Louise, Thijs, Vincent, Rinkel, Gabriel J. E., Hemmen, Thomas M.

“…Background Stroke is among the leading causes of morbidity and mortality worldwide. Without reliable prediction models and outcome measurements, comparison of…”
Get full text

Endovascular Therapeutic Hypothermia for Acute Ischemic Stroke: ICTuS 2/3 Protocol by Lyden, Patrick D., Hemmen, Thomas M., Grotta, James, Rapp, Karen, Raman, Rema

“…Therapeutic hypothermia improves neurological outcome after out-of-hospital cardiac arrest or neonatal hypoxic–ischemic injury. Although supported by…”
Get full text

A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke by HALEY, E. Clarke, LYDEN, Patrick D, JOHNSTON, Karen C, HEMMEN, Thomas M

“…Recombinant tissue-type plasminogen activator (rtPA) is the only approved treatment in acute ischemic stroke. However, intracerebral hemorrhage (ICH) occurs in…”
Get full text

Identification of Nonischemic Stroke Mimics Among 411 Code Strokes at the University of California, San Diego, Stroke Center by Hemmen, Thomas M., MD, PhD, Meyer, Brett C., MD, McClean, Teri L., RN, Lyden, Patrick D., MD

“…Background Code Stroke systems are widely used to expedite emergency treatment of patients with stroke. Code Stroke for mimic patients–those without a stroke…”
Get full text

Defining Mild Stroke: Outcomes Analysis of Treated and Untreated Mild Stroke Patients by Spokoyny, Ilana, MD, Raman, Rema, PhD, Ernstrom, Karin, MS, Khatri, Pooja, MD, MSc, Meyer, Dawn M., PhD, RN, FNP-C, Hemmen, Thomas M., MD, PhD, Meyer, Brett C., MD

“…Background Mild deficit is a relative contraindication to administration of intravenous recombinant tissue plasminogen activator (IV rtPA) for acute ischemic…”
Get full text

Transcranial Doppler After Endovascular Treatment to Evaluate Collateral Status and Outcomes in Patients With Large‐Vessel Occlusion by Bavarsad Shahripour, Reza, Azarpazhooh, Mahmoud Reza, Akhuanzada, Humayon, Tarpley, Jason W., Borhani‐Haghighi, Afshin, Agrawal, Kunal, Modir, Royya, Meyer, Brett, Hemmen, Thomas M, Meyer, Dawn

“…BackgroundRecent advances in endovascular therapy (EVT) have led to significant improvements in functional outcomes of patients with stroke. However, early…”
Get full text

Diffusion-weighted Imaging–Fluid Attenuated Inversion Recovery Mismatch in Nocturnal Stroke Patients with Unknown Time of Onset by Huisa, Branko N., MD, Liebeskind, David S., MD, Raman, Rema, PhD, Hao, Qing, MS, Meyer, Brett C., MD, Meyer, Dawn M., PhD, Hemmen, Thomas M., MD, PhD

“…Background More than a quarter of patients with ischemic stroke (IS) are excluded from thrombolysis because of an unknown time of symptom onset. Recent…”
Get full text

The “DeyeCOM Sign”: Predictive Value in Acute Stroke Code Evaluations by Coffman, Clarity R., MPH, Raman, Rema, PhD, Ernstrom, Karin, MS, Herial, Nabeel A., MD, MPH, Schlick, Konrad H., MD, Rapp, Karen, RN, Modir, Royya F., MD, Meyer, Dawn M., NP, PhD, Hemmen, Thomas M., MD, PhD, Meyer, Brett C., MD

“…Background Rapid diagnosis in stroke is critical. Computed tomography is often performed initially, even before a neurologic examination. Gaze deviation has…”
Get full text

Intravenous Tissue Plasminogen Activator for Patients with Minor Ischemic Stroke by Huisa, Branko N., MD, Raman, Rema, PhD, Neil, Will, MD, Ernstrom, Karin, MS, Hemmen, Thomas M., MD, PhD

“…Background Patients with minor ischemic stroke (MIS) are frequently excluded from thrombolytic therapy. Denial of therapy to these patients, however, remains…”
Get full text

Imaging Negative Stroke: Diagnoses and Outcomes in Intravenous Tissue Plasminogen Activator–Treated Patients by Spokoyny, Ilana, MD, Raman, Rema, PhD, Ernstrom, Karin, MS, Meyer, Brett C., MD, Hemmen, Thomas M., MD, PhD

“…Background Intravenous (IV) Alteplase (tissue plasminogen activator [t-PA]) improves outcome in patients with acute ischemic stroke. Of those with full…”
Get full text

Feasibility and Safety of Using External Counterpulsation to Augment Cerebral Blood Flow in Acute Ischemic Stroke—The Counterpulsation to Upgrade Forward Flow in Stroke (CUFFS) Trial by Guluma, Kama Z., MD, Liebeskind, David S., MD, Raman, Rema, PhD, Rapp, Karen S., RN, Ernstrom, Karin B., MS, Alexandrov, Andrei V., MD, Shahripour, Reza B., MD, Barlinn, Kristian, MD, MSc, Starkman, Sidney, MD, Grunberg, Ileana D., RN, Hemmen, Thomas M., MD, PhD, Meyer, Brett C., MD, Alexandrov, Anne W., PhD

“…Background: External counterpulsation (ECP) increases perfusion to a variety of organs and may be helpful for acute stroke. Methods: We conducted a…”
Get full text

Therapeutic hypothermia for brain ischemia: where have we come and where do we go? by Yenari, Midori A, Hemmen, Thomas M

“…Mild hypothermia is an established neuroprotectant in the laboratory, showing remarkable and consistent effects across multiple laboratories and models of…”
Get full text

Assessment of Long-Term Outcomes for the STRokE DOC Telemedicine Trial by Meyer, Brett C., MD, Raman, Rema, PhD, Ernstrom, Karin, MS, Tafreshi, Gilda M., MD, Huisa, Branko, MD, Stemer, Andrew B., MD, Hemmen, Thomas M., MD

“…Telemedicine can provide stroke evaluations in locations with limited available expertise. The reliability of telestroke has been established. Decision making…”
Get full text

Pooled Assessment of Computed Tomography Interpretation by Vascular Neurologists in the STRokE DOC Telestroke Network by Spokoyny, Ilana, MD, Raman, Rema, PhD, Ernstrom, Karin, MS, Demaerschalk, Bart M., MD, Lyden, Patrick D., MD, Hemmen, Thomas M., MD, PhD, Guzik, Amy K., MD, Chen, James Y., MD, Meyer, Brett C., MD

“…Background and Purpose The objective of this pooled analysis was to determine the level of agreement between central read and each of 2 groups (spoke…”
Get full text

Intravenous Thrombolysis Plus Hypothermia for Acute Treatment of Ischemic Stroke (ICTuS-L): Final Results by HEMMEN, Thomas M, RAMAN, Rema, GULUMA, Kama Z, MEYER, Brett C, GOMES, Joao A, CRUZ-FLORES, Salvador, WIJMAN, Christine A, RAPP, Karen S, GROTTA, James C, LYDEN, Patrick D

“…Induced hypothermia is a promising neuroprotective therapy. We studied the feasibility and safety of hypothermia and thrombolysis after acute ischemic stroke…”
Get full text

Does Symptom Onset to Primary Stroke Center Time Goals Affect Stroke Outcome? by Chee, Bryant, BS, Raman, Rema, PhD, Ernstrom, Karin, MS, Guzik, Amy K., MD, Hemmen, Thomas M., PhD, Rapp, Karen S., RN, Meyer, Brett C., MD, Meyer, Dawn M., PhD

“…Background Treating acute ischemic stroke (AIS) within 4.5 hours and door-to-needle time of less than 60 minutes may optimize recovery. It is unknown if onset…”
Get full text

Induced hypothermia for acute stroke by HEMMEN, Thomas M, LYDEN, Patrick D

“…Induced hypothermia is one of the most promising neuroprotective therapies. Technological limitations and homeostatic mechanisms that maintain core body…”
Get full text

Analysis of the National Institute of Neurological Disorders and Stroke Tissue Plasminogen Activator Studies Following European Cooperative Acute Stroke Study III Patient Selection Criteria by Hemmen, Thomas M., MD, PhD, Rapp, Karen S., RN, Emond, Jennifer A., MS, Raman, Rema, PhD, Lyden, Patrick D., MD, FAAN

“…Background In 1995 two studies by the National Institute of Neurological Disorders and Stroke (NINDS) proved that intravenous tissue plasminogen activator…”
Get full text

Ransomware Attack Associated With Disruptions at Adjacent Emergency Departments in the US by Dameff, Christian, Tully, Jeffrey, Chan, Theodore C, Castillo, Edward M, Savage, Stefan, Maysent, Patricia, Hemmen, Thomas M, Clay, Brian J, Longhurst, Christopher A

“…Cyberattacks on health care delivery organizations are increasing in frequency and sophistication. Ransomware infections have been associated with significant…”
Get full text